Thailand
· Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 5.50 billion. The enterprise value is 5.38 billion.
| Market Cap | 5.50B |
| Enterprise Value | 5.38B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | -1.04% |
| Owned by Insiders (%) | 65.86% |
| Owned by Institutions (%) | 1.42% |
| Float | 62.92M |
Valuation Ratios
The trailing PE ratio is 15.87 and the forward PE ratio is 14.01. BKK:KLINIQ's PEG ratio is 1.40.
| PE Ratio | 15.87 |
| Forward PE | 14.01 |
| PS Ratio | 1.69 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 3.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.12, with an EV/FCF ratio of 17.89.
| EV / Earnings | 15.51 |
| EV / Sales | 1.65 |
| EV / EBITDA | 7.12 |
| EV / EBIT | 12.06 |
| EV / FCF | 17.89 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.32 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 2.19 |
| Interest Coverage | 17.70 |
Financial Efficiency
Return on equity (ROE) is 20.22% and return on invested capital (ROIC) is 11.91%.
| Return on Equity (ROE) | 20.22% |
| Return on Assets (ROA) | 9.01% |
| Return on Invested Capital (ROIC) | 11.91% |
| Return on Capital Employed (ROCE) | 19.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.05 |
| Inventory Turnover | 5.56 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 86.32 million in taxes.
| Income Tax | 86.32M |
| Effective Tax Rate | 19.91% |
Stock Price Statistics
The stock price has decreased by -22.48% in the last 52 weeks. The beta is -0.11, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -22.48% |
| 50-Day Moving Average | 22.77 |
| 200-Day Moving Average | 27.71 |
| Relative Strength Index (RSI) | 58.65 |
| Average Volume (20 Days) | 476,699 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.26 billion and earned 346.86 million in profits. Earnings per share was 1.57.
| Revenue | 3.26B |
| Gross Profit | 1.69B |
| Operating Income | 446.05M |
| Pretax Income | 433.51M |
| Net Income | 346.86M |
| EBITDA | 627.31M |
| EBIT | 446.05M |
| Earnings Per Share (EPS) | 1.57 |
Balance Sheet
The company has 789.25 million in cash and 659.62 million in debt, giving a net cash position of 129.64 million or 0.59 per share.
| Cash & Cash Equivalents | 789.25M |
| Total Debt | 659.62M |
| Net Cash | 129.64M |
| Net Cash Per Share | 0.59 |
| Equity (Book Value) | 1.75B |
| Book Value Per Share | 7.98 |
| Working Capital | 289.92M |
Cash Flow
In the last 12 months, operating cash flow was 677.03 million and capital expenditures -376.33 million, giving a free cash flow of 300.70 million.
| Operating Cash Flow | 677.03M |
| Capital Expenditures | -376.33M |
| Free Cash Flow | 300.70M |
| FCF Per Share | 1.37 |
Margins
Gross margin is 51.77%, with operating and profit margins of 13.69% and 10.64%.
| Gross Margin | 51.77% |
| Operating Margin | 13.69% |
| Pretax Margin | 13.30% |
| Profit Margin | 10.64% |
| EBITDA Margin | 19.25% |
| EBIT Margin | 13.69% |
| FCF Margin | 9.23% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 5.60%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 5.60% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 92.10% |
| Buyback Yield | -0.22% |
| Shareholder Yield | 5.22% |
| Earnings Yield | 6.31% |
| FCF Yield | 5.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |